Data / Drug companies / Janssen Pharmaceutical Sciences Unlimited Company
Janssen Pharmaceutical Sciences Unlimited Company: 22 products in the FDA NDC directory, labeler code 65267
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Janssen Pharmaceutical Sciences Unlimited Company (labeler code 65267) lists 22 products in the FDA National Drug Code Directory. By type: 19 bulk ingredients, 3 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on August 9, 2023.
The request: Watch Janssen Pharmaceutical Sciences Unlimited Company (FDA labeler code 65267): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 65267
- Products in commercial distribution
- 22
- Packages
- 23
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule II 5, Schedule III 3
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 11, 1992
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 19 | 86.4% |
| Drugs for further processing | 3 | 13.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 19 | 86.4% |
| Drugs for further processing | 3 | 13.6% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 15 | 68.2% |
| Solution | 4 | 18.2% |
| Injection | 2 | 9.1% |
| Pellet | 1 | 4.5% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Talquetamab | 65267-901 | Solution | Drugs for further processing | August 9, 2023 |
| Teclistamab | 65267-897 | Injection | Bulk ingredients | August 28, 2022 |
| Esketamine | 65267-117 | Powder | Bulk ingredients | March 5, 2019 |
| Apalutamide | 65267-116 | Powder | Bulk ingredients | February 14, 2018 |
| Methylphenidate hydrochloride | 65267-115 | Powder | Bulk ingredients | January 31, 2017 |
| Siltuximab dpc | 65267-903 | Solution | Drugs for further processing | April 23, 2014 |
| Buprenorphine | 65267-203 | Powder | Bulk ingredients | April 30, 2012 |
| Buprenorphine hydrochloride | 65267-104 | Powder | Bulk ingredients | April 30, 2012 |
| Rilpivirine hydrochloride | 65267-501 | Powder | Bulk ingredients | July 19, 2010 |
| Ustekinumab | 65267-896 | Injection | Bulk ingredients | September 28, 2009 |
| Golimumab | 65267-899 | Solution | Bulk ingredients | April 24, 2009 |
| Tapentadol hydrochloride | 65267-101 | Powder | Bulk ingredients | January 22, 2009 |
| Tapentadol hydrochloride | 65267-101 | Powder | Bulk ingredients | January 22, 2009 |
| Methylphenidate hydrochloride | 65267-114 | Powder | Bulk ingredients | December 19, 2008 |
| Darunavir ethanolate | 65267-210 | Powder | Bulk ingredients | February 25, 2008 |
| Paliperidone | 65267-201 | Powder | Bulk ingredients | December 19, 2006 |
| Hydromorphone hydrochloride | 65267-057 | Powder | Bulk ingredients | June 29, 2006 |
| Risperidone | 65267-895 | Powder | Bulk ingredients | October 29, 2003 |
| Topiramate | 65267-103 | Powder | Bulk ingredients | September 12, 2003 |
| Infliximab | 65267-898 | Solution | Bulk ingredients | August 24, 1998 |
| Risperidone | 65267-303 | Powder | Bulk ingredients | December 29, 1993 |
| Itraconazole pellets | 65267-900 | Pellet | Drugs for further processing | September 11, 1992 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.